Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/27/2026 | Q4 | $7.1B | -- | -- | $4.39 | -- |
| 10/30/2025 | Q3 | $6B | $6.1B | $2.22 | $3.13 | -$0.91 |
| 07/31/2025 | Q2 | $5.9B | $6B | $2.29 | $3.07 | -$0.78 |
| 05/01/2025 | Q1 | $5.7B | $5.9B | $1.69 | $2.73 | -$1.04 |
| 01/28/2025 | Q4 | $6.4B | $6.4B | $1.41 | $3.87 | -$2.46 |
| 10/29/2024 | Q3 | $5.4B | $5.5B | $2.16 | $2.77 | -$0.61 |
| 07/30/2024 | Q2 | $5.4B | $5.4B | $2.14 | $2.79 | -$0.65 |
| 04/30/2024 | Q1 | $5.1B | $5.2B | $2.05 | $2.36 | -$0.31 |
| 01/30/2024 | Q4 | $5.6B | $5.8B | $2.98 | $3.27 | -$0.29 |
| 11/02/2023 | Q3 | -- | $4.9B | $1.80 | -- | -- |
| 08/03/2023 | Q2 | -- | $5B | $1.92 | -- | -- |
| 05/01/2023 | Q1 | -- | $4.8B | $1.54 | -- | -- |
| 01/31/2023 | Q4 | -- | $5.2B | $1.47 | -- | -- |
| 10/31/2022 | Q3 | -- | $4.5B | $2.14 | -- | -- |
| 07/26/2022 | Q2 | -- | $4.5B | $1.72 | -- | -- |
| 04/28/2022 | Q1 | -- | $4.3B | $0.84 | -- | -- |
| 01/27/2022 | Q4 | -- | $4.7B | $1.73 | -- | -- |
| 10/28/2021 | Q3 | -- | $4.2B | $1.14 | -- | -- |
| 07/27/2021 | Q2 | -- | $4.3B | $1.55 | -- | -- |
| 04/27/2021 | Q1 | -- | $4B | $0.79 | -- | -- |
| 01/27/2021 | Q4 | -- | $4.3B | $1.49 | -- | -- |
| 10/29/2020 | Q3 | -- | $3.7B | $1.63 | -- | -- |
| 07/30/2020 | Q2 | -- | $2.8B | -$0.22 | -- | -- |
| 04/30/2020 | Q1 | -- | $3.6B | $1.30 | -- | -- |
| 01/28/2020 | Q4 | -- | $4.1B | $1.91 | -- | -- |
| 10/29/2019 | Q3 | -- | $3.6B | $1.23 | -- | -- |
| 07/25/2019 | Q2 | -- | $3.7B | $1.26 | -- | -- |
| 04/23/2019 | Q1 | -- | $3.5B | $1.09 | -- | -- |
| 01/29/2019 | Q4 | -- | $3.8B | $5.44 | -- | -- |
| 10/25/2018 | Q3 | -- | $3.2B | $1.55 | -- | -- |
| 07/24/2018 | Q2 | -- | $3.3B | $1.19 | -- | -- |
| 04/26/2018 | Q1 | -- | $3.2B | $1.16 | -- | -- |
| 01/30/2018 | Q4 | -- | $3.5B | -$0.66 | -- | -- |
| 10/26/2017 | Q3 | -- | $3B | $1.14 | -- | -- |
| 07/27/2017 | Q2 | -- | $3B | $1.03 | -- | -- |
| 04/25/2017 | Q1 | -- | $3B | $1.17 | -- | -- |
| 01/24/2017 | Q4 | -- | $3.2B | $1.34 | -- | -- |
| 10/27/2016 | Q3 | -- | $2.8B | $0.94 | -- | -- |
| 07/21/2016 | Q2 | -- | $2.8B | $1.00 | -- | -- |
| 04/20/2016 | Q1 | -- | $2.5B | $1.07 | -- | -- |
| 01/26/2016 | Q4 | -- | -- | -- | -- | -- |
Stryker Corp. reported $6.1B worth of top line sales in its most recent quarter.
Stryker Corp. announced earnings per share of $2.22 which represents a miss of analyst forecast a $3.13 per share.
Stryker Corp. reported $3.7B that represents $9.69 per share over the last quarter.
Stryker Corp.'s earnings are forecast to grow from $7.76 per share to $12.06 per share next year representing an increase of 74.6%.
Stryker Corp.'s next earnings date is January 27, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.